ASD
Defiance Autism Impact ETF
ASD
Closed
$28.16
Closed
-(-)
At close
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply
About
ASD was created on 2026-06-01 by Defiance. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 1.4m in AUM and 40 holdings. ASD tracks an equal-weighted index of companies from developed markets supporting individuals on the autism spectrum and broader community. The fund donates profits to organizations focused on autism care, research, and access to resources.
Company
Defiance
Asset class
Equity
Inception date
2026
Investment segment
Health Care
ISIN
US2689613311
Website
Key stats
Open
$0.00
Volume
50.00
AUM
$1.40M
Prev. close
$27.71
Expense ratio
0.79%
P/E
15.78
$0.00
Day’s Range
$0.00
$24.80
52W Range
$28.52
What’s in the fund
41
Total holdings
Definium Therapeutics Inc Ordinary Shares
4.28%
Neuren Pharmaceuticals Ltd
3.83%
LifeStance Health Group Inc Ordinary Shares
3.37%
ACADIA Pharmaceuticals Inc
3.27%
Otsuka Holdings Co Ltd
3.27%
Repligen Corp
3.22%
Revvity Inc
3.02%
Anavex Life Sciences Corp
2.95%
Acadia Healthcare Co Inc
2.86%
Others
69.93%
Returns
Performance
_
Difference
_
Defiance Autism Impact ETF
Jun
25
Dividends
The last payment date was Jun 25, 2026
Div. per Share
$0.01
Div. Yield
0.02%
Div. Growth YoY
-
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply